Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Managing fatigue in patients with multiple sclerosis.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Physiopathology of symptoms and signs in multiple sclerosis.
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
Memory rehabilitation for people with multiple sclerosis.
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
High dose naltrexone for dyskinesias induced by levodopa.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Amiloride HCI Tablets, USP 5 mg
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
High-field imaging of neurodegenerative diseases.
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Study Suggests Targeting B Cells May Help with MS
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Tysabri
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.

Pages